AST is used in conjunction with other hepatic enzymes, such as alanine aminotransferase (ALT), as a clinical biomarker of liver diseases including viral and alcoholic hepatitis, cirrhosis, and metastatic carcinoma in the liver [2,3]. This evidence concerns the gene GPT and liver disorder.